Impact BioMedical Inc. (IBO)

ASE – Real Time Price. Currency in USD

0.61

-0.02 (-3.01%)

Market open: May 13, 2026, 9:50 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

32K

Cost of goods sold

-2M

-1M

Gross Profit

-2M

-1M

Operating expenses (excl. COGS)

-3M

-2M

-3M

-2M

Operating Income

-4M

-3M

-4M

-3M

Non-operating income, total

-10M

-21M

-379K

-4M

Pretax income

-14M

-25M

-4M

-8M

Equity in earnings

Taxes

-33K

621K

Non-controlling/minority interest

32K

62K

71K

204K

After tax other income/expense

Net income before discontinued operations

-12M

-25M

-4M

-7M

Impact BioMedical Inc. (IBO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Impact BioMedical Inc. (IBO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Impact BioMedical Inc. (IBO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Impact BioMedical Inc. (IBO)

Income Statement (Annual)

Income Statement (Annual)